Epsilon M&A Deal Report - Kinaxo Biotechnologies
Transaction Multiples for the Valuation of Private Companies
Evotec / Kinaxo Biotechnologies
No EMAT :
25654
Announced Date :
09/02/2011
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Evotec
Target :
Kinaxo Biotechnologies
Country :
Germany
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2005, Kinaxo Biotechnologies - a spin-off of the Max Planck Institute of Biochemistry in Martinsried - is a biotechnology company specialized in chemical proteomics methods to support the...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
ns |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 43
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 31/01/2010 | Cephalon | Mepha Pharma | Switzerland | *** | 25634 |
| 31/05/2011 | Bastide Le Confort Medical (BLCM) | A a Z Sante | France | * | 25598 |
Source: Epsilon Research / EMAT
